Compass Therapeutics, Inc. (CMPX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -17.27M | -13.25M | -10.85M | -11.83M | -13.21M | -9.16M | -11.05M | -10.75M | -13.89M | -12.35M | -5.92M | -10.11M | -12.23M | -10.64M | -10.94M | -4.6M | -7.94M | -4.67M | -3.46M | -5.94M |
| Operating CF Margin % | - | - | - | - | - | - | - | -1265.18% | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -30.75% | -44.66% | 1.83% | -10.02% | 4.9% | 25.84% | -86.61% | -6.34% | -13.57% | -16.1% | 45.88% | -119.85% | -53.98% | -128.1% | -216.52% | 22.55% | -41.69% | 29.03% | 51.78% | -12.06% |
| Net Income | -18.32M | -15.72M | -14.26M | -19.88M | -16.63M | -15.03M | -10.48M | -13.08M | -10.79M | -13.41M | -9.96M | -11.28M | -7.84M | -11.59M | -11.97M | -8.49M | -7.16M | -12.98M | -5.98M | -55.8M |
| Depreciation & Amortization | 368K | -981K | 371K | -226K | 364K | 359K | 465K | 466K | 463K | 468K | 466K | 475K | 481K | 484K | 487K | 498K | 435K | 396K | 406K | 409K |
| Stock-Based Compensation | 0 | 1.82M | 1.24M | 2.79M | 2.51M | 2.24M | 2.2M | 2.12M | 2M | 1.6M | 1.63M | 1.63M | 1.27M | 1.02M | 1.29M | 1.44M | 1.57M | 1.19M | 987K | 908K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33K | -31K | 50.62M |
| Other Non-Cash Items | 4.87M | 155K | -375K | 465K | 26K | -270K | -278K | -727K | 5.79M | -60K | -786K | -1.03M | -593K | -611K | -300K | 40K | 3.06M | 6K | 13K | 7K |
| Working Capital Changes | -4.19M | 1.46M | 2.18M | 5.02M | 521K | 3.54M | -2.96M | 462K | -5.19M | -195K | 2.74M | 97K | -5.55M | 55K | -441K | 1.91M | -2.79M | 6.7M | 1.15M | -2.08M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -679K | -1.51M | 500K | 1.02M | -672K | 1.29M | -232K | 338K | -3.24M | 1.78M | 1.58M | -401K | -2.26M | 621K | -3.69M | 6.2M | -611K | -1K | 309K | -502K |
| Cash from Investing | 38.43M | -3.38M | -95.16M | -6.36M | 11.59M | 15.37M | 29.02M | 6.48M | -4.1M | 6.31M | 17.05M | -667K | 4.27M | -46.65M | 1.18M | -105.54M | -193K | -776K | -367K | -614K |
| Capital Expenditures | -82K | 0 | -7K | 0 | -18K | 0 | -44K | 0 | 0 | -9K | -10K | -11K | 0 | -54K | -27K | -131K | -194K | -777K | -367K | -296K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.4K | -17.06K | 656 | 0 | 370K | -1.21K | 175K | 1K | 1K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.1K | 6.32K | 17.06K | -656 | 4.27K | -370K | 1.21K | 369K | 1K | 1K | 0 | -318K |
| Cash from Financing | 3.37M | 1.06M | 129.36M | 0 | -815K | -94K | -2K | 1K | 17.43M | -158K | 21K | 3.03M | 41K | 75.75M | 5K | 0 | 0 | 124.24M | -1.88M | -1.88M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | 3.85M | 1.27M | 138M | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -136 | -159 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -489K | -212K | -8.64M | 0 | -815K | -94K | -2K | 1K | -136K | -159K | 21 | 3.03K | 41 | -480K | 5 | 0 | 0 | -281K | 0 | 0 |
| Net Change in Cash | 24.52M | -15.57M | 23.36M | -18.19M | -2.44M | 6.11M | 17.96M | -4.27M | -554K | -6.2M | 11.15M | -7.75M | -7.92M | 18.46M | -9.76M | -110.14M | -8.13M | 118.8M | -5.7M | -8.43M |
| Free Cash Flow | -17.35M | -13.25M | -10.86M | -11.83M | -13.23M | -9.16M | -11.1M | -10.75M | -13.89M | -12.36M | -5.93M | -10.12M | -12.23M | -10.7M | -10.97M | -4.73M | -8.14M | -5.44M | -3.82M | -6.24M |
| FCF Margin % | - | - | - | - | - | - | - | -1265.18% | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -31.19% | -44.66% | 2.15% | -10.02% | 4.77% | 25.89% | -87.04% | -6.22% | -13.57% | -15.6% | 45.92% | -113.99% | -50.31% | -96.53% | -186.85% | 24.12% | -41.92% | 18.24% | 46.71% | -17.55% |
| FCF per Share | -0.09 | -0.07 | -0.08 | -0.09 | -0.10 | -0.07 | -0.08 | -0.08 | -0.10 | -0.10 | -0.05 | -0.08 | -0.10 | -0.10 | -0.11 | -0.05 | -0.08 | -0.10 | -0.06 | -0.12 |
| FCF Conversion (FCF/Net Income) | 0.94x | 0.84x | 0.76x | 0.60x | 0.79x | 0.61x | 1.05x | 0.82x | 1.29x | 0.92x | 0.59x | 0.90x | 1.56x | 0.92x | 0.91x | 0.54x | 1.11x | 0.36x | 0.58x | 0.11x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |